Cargando…
Corrigendum to: Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2) [Pharmacol. Res. 156 (2020) 104761]
| Autores principales: | , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603740/ https://www.ncbi.nlm.nih.gov/pubmed/34802883 http://dx.doi.org/10.1016/j.phrs.2021.105907 |
| _version_ | 1784601815958945792 |
|---|---|
| author | Runfeng, Li Yunlong, Hou Jicheng, Huang Weiqi, Pan Qinhai, Ma Yongxia, Shi Chufang, Li Jin, Zhao Zhenhua, Jia Haiming, Jiang Kui, Zheng Shuxiang, Huang Jun, Dai Xiaobo, Li Xiaotao, Hou Lin, Wang Nanshan, Zhong Zifeng, Yang |
| author_facet | Runfeng, Li Yunlong, Hou Jicheng, Huang Weiqi, Pan Qinhai, Ma Yongxia, Shi Chufang, Li Jin, Zhao Zhenhua, Jia Haiming, Jiang Kui, Zheng Shuxiang, Huang Jun, Dai Xiaobo, Li Xiaotao, Hou Lin, Wang Nanshan, Zhong Zifeng, Yang |
| author_sort | Runfeng, Li |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8603740 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-86037402021-11-22 Corrigendum to: Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2) [Pharmacol. Res. 156 (2020) 104761] Runfeng, Li Yunlong, Hou Jicheng, Huang Weiqi, Pan Qinhai, Ma Yongxia, Shi Chufang, Li Jin, Zhao Zhenhua, Jia Haiming, Jiang Kui, Zheng Shuxiang, Huang Jun, Dai Xiaobo, Li Xiaotao, Hou Lin, Wang Nanshan, Zhong Zifeng, Yang Pharmacol Res Article Published by Elsevier Ltd. 2021-12 2021-11-19 /pmc/articles/PMC8603740/ /pubmed/34802883 http://dx.doi.org/10.1016/j.phrs.2021.105907 Text en © 2021 Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Runfeng, Li Yunlong, Hou Jicheng, Huang Weiqi, Pan Qinhai, Ma Yongxia, Shi Chufang, Li Jin, Zhao Zhenhua, Jia Haiming, Jiang Kui, Zheng Shuxiang, Huang Jun, Dai Xiaobo, Li Xiaotao, Hou Lin, Wang Nanshan, Zhong Zifeng, Yang Corrigendum to: Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2) [Pharmacol. Res. 156 (2020) 104761] |
| title | Corrigendum to: Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2) [Pharmacol. Res. 156 (2020) 104761] |
| title_full | Corrigendum to: Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2) [Pharmacol. Res. 156 (2020) 104761] |
| title_fullStr | Corrigendum to: Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2) [Pharmacol. Res. 156 (2020) 104761] |
| title_full_unstemmed | Corrigendum to: Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2) [Pharmacol. Res. 156 (2020) 104761] |
| title_short | Corrigendum to: Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2) [Pharmacol. Res. 156 (2020) 104761] |
| title_sort | corrigendum to: lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (sars-cov-2) [pharmacol. res. 156 (2020) 104761] |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603740/ https://www.ncbi.nlm.nih.gov/pubmed/34802883 http://dx.doi.org/10.1016/j.phrs.2021.105907 |
| work_keys_str_mv | AT runfengli corrigendumtolianhuaqingwenexertsantiviralandantiinflammatoryactivityagainstnovelcoronavirussarscov2pharmacolres1562020104761 AT yunlonghou corrigendumtolianhuaqingwenexertsantiviralandantiinflammatoryactivityagainstnovelcoronavirussarscov2pharmacolres1562020104761 AT jichenghuang corrigendumtolianhuaqingwenexertsantiviralandantiinflammatoryactivityagainstnovelcoronavirussarscov2pharmacolres1562020104761 AT weiqipan corrigendumtolianhuaqingwenexertsantiviralandantiinflammatoryactivityagainstnovelcoronavirussarscov2pharmacolres1562020104761 AT qinhaima corrigendumtolianhuaqingwenexertsantiviralandantiinflammatoryactivityagainstnovelcoronavirussarscov2pharmacolres1562020104761 AT yongxiashi corrigendumtolianhuaqingwenexertsantiviralandantiinflammatoryactivityagainstnovelcoronavirussarscov2pharmacolres1562020104761 AT chufangli corrigendumtolianhuaqingwenexertsantiviralandantiinflammatoryactivityagainstnovelcoronavirussarscov2pharmacolres1562020104761 AT jinzhao corrigendumtolianhuaqingwenexertsantiviralandantiinflammatoryactivityagainstnovelcoronavirussarscov2pharmacolres1562020104761 AT zhenhuajia corrigendumtolianhuaqingwenexertsantiviralandantiinflammatoryactivityagainstnovelcoronavirussarscov2pharmacolres1562020104761 AT haimingjiang corrigendumtolianhuaqingwenexertsantiviralandantiinflammatoryactivityagainstnovelcoronavirussarscov2pharmacolres1562020104761 AT kuizheng corrigendumtolianhuaqingwenexertsantiviralandantiinflammatoryactivityagainstnovelcoronavirussarscov2pharmacolres1562020104761 AT shuxianghuang corrigendumtolianhuaqingwenexertsantiviralandantiinflammatoryactivityagainstnovelcoronavirussarscov2pharmacolres1562020104761 AT jundai corrigendumtolianhuaqingwenexertsantiviralandantiinflammatoryactivityagainstnovelcoronavirussarscov2pharmacolres1562020104761 AT xiaoboli corrigendumtolianhuaqingwenexertsantiviralandantiinflammatoryactivityagainstnovelcoronavirussarscov2pharmacolres1562020104761 AT xiaotaohou corrigendumtolianhuaqingwenexertsantiviralandantiinflammatoryactivityagainstnovelcoronavirussarscov2pharmacolres1562020104761 AT linwang corrigendumtolianhuaqingwenexertsantiviralandantiinflammatoryactivityagainstnovelcoronavirussarscov2pharmacolres1562020104761 AT nanshanzhong corrigendumtolianhuaqingwenexertsantiviralandantiinflammatoryactivityagainstnovelcoronavirussarscov2pharmacolres1562020104761 AT zifengyang corrigendumtolianhuaqingwenexertsantiviralandantiinflammatoryactivityagainstnovelcoronavirussarscov2pharmacolres1562020104761 |